57 results
FWP
LGVN
Longeveron Inc - Ordinary Shares
8 Apr 24
Free writing prospectus
8:45am
to patients and creating sustainable value for our shareholders.
Our lead investigational product is Lomecel-B™, which is derived from culture-expanded
424B5
8rzhcsdvqaxl8hifalek
22 Dec 23
Prospectus supplement for primary offering
8:36am
424B5
7mkmols17nmktzqugqq
13 Oct 23
Prospectus supplement for primary offering
6:07am
8-K
EX-99.1
5d3gc
1 Sep 22
Regulation FD Disclosure
1:05pm
8-K
EX-99.1
4bp9b0rce80flazuwq0
12 Aug 22
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2022 Financial Results
9:26am
8-K
EX-99.1
86jqyl
13 May 22
Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
9:50am
8-K
EX-99.1
ro6dux k8ot
9 May 22
Longeveron Announces CEO Transition
4:26pm
S-3
h0qrbx 1mdwwy00lqw
5 Apr 22
Shelf registration
4:28pm
8-K
EX-99.1
hikcbzh8
5 Apr 22
Longeveron Expands Executive Leadership Team; Appoints
4:01pm
8-K
EX-99.1
rg9nw743ijna7m74c0o
11 Mar 22
Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
8:45am